Effect of bortezomib on the treatment of multiple myeloma: a systematic review protocol

INTRODUCTION: Multiple myeloma (MM) is an incurable malignant neoplasm that accounts for approximately 1% of all cancers and 10% of haematological malignancies. Bortezomib is one of the most commonly used medications in first-line treatment and subsequent relapses, either as a single agent or in com...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantadori, Lucas Oliveira, Gaiolla, Rafael Dezen, Nunes-Nogueira, Vania dos Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240935/
https://www.ncbi.nlm.nih.gov/pubmed/35768117
http://dx.doi.org/10.1136/bmjopen-2022-061808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240935/
https://www.ncbi.nlm.nih.gov/pubmed/35768117
http://dx.doi.org/10.1136/bmjopen-2022-061808

Ejemplares similares